$22.11
-2.00-8.27%
Last update: Nov 10, 2:35 PM
Bright Minds Biosciences Inc
DRUGNASDAQ
Bright Minds Biosciences fell 59.3% from $59.30 to $24.11, behind the S&P 500's +10.5%. Its worst day was Nov 2 (−52.3%), and its low came Nov 4 at $18.96.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Bright Minds Biosciences closed at its highest level of the year, 61.9% above where the year started.
+3.0% · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
EPS of $-0.97 beat the $-1.34 estimate on $0.00 revenue.
−3.3% · S&P 500 +0.1%
EPS of $-1.09 beat the $-1.39 estimate on $0.00 revenue.
+11.1% · S&P 500 +1.0%
EPS of $-0.17 beat the $-1.39 estimate on $0.00 revenue.
+4.0% · S&P 500 −0.5%
Bright Minds Biosciences closed at its lowest level of the year, 68.0% below where the year started.
−12.0% · S&P 500 +1.7%
Where it ended: a close of $24.11 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 12, 2027 (EPS est. $-1.09).
Nothing in the past 12 months.
All DRUG dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for DRUG and SPY from Benzinga historical bars. Not investment advice.
